It has already been confirmed that serum levels of leptin increased significantly in patients with SLE, a finding that has been replicated in many studies from diverse countries, revealing that leptin can be considered as a novel biomarker in predicting the risk of SLE (80–83). This evidence concerns the gene LEP and systemic lupus erythematosus.